Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

[1]  N. Badjatia,et al.  The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society , 2017, Neurocritical Care.

[2]  K. Haase,et al.  Variability in Glycemic Control with Temperature Transitions during Therapeutic Hypothermia , 2017, Critical care research and practice.

[3]  J. Studnek,et al.  Factors Associated with Delayed Cooling in Cardiac Arrest Patients. , 2017, Therapeutic hypothermia and temperature management.

[4]  Nicola J. Robertson,et al.  Dexmedetomidine Combined with Therapeutic Hypothermia Is Associated with Cardiovascular Instability and Neurotoxicity in a Piglet Model of Perinatal Asphyxia , 2017, Developmental Neuroscience.

[5]  J. Finn,et al.  Changing target temperature from 33°C to 36°C in the ICU management of out-of-hospital cardiac arrest: A before and after study. , 2017, Resuscitation.

[6]  A. Janata,et al.  Time to Cooling Is Associated with Resuscitation Outcomes. , 2016 .

[7]  D. Seder,et al.  Analgesia, sedation, and neuromuscular blockade during targeted temperature management after cardiac arrest. , 2015, Best practice & research. Clinical anaesthesiology.

[8]  J. Reignier,et al.  Neuromuscular blockade during therapeutic hypothermia after cardiac arrest: observational study of neurological and infectious outcomes. , 2014, Resuscitation.

[9]  J. Sleigh,et al.  Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model , 2014, Acta anaesthesiologica Scandinavica.

[10]  P. Kudenchuk,et al.  Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. , 2014, JAMA.

[11]  Yeonho You,et al.  Association of blood glucose variability with outcomes in comatose cardiac arrest survivors treated with therapeutic hypothermia. , 2013, The American journal of emergency medicine.

[12]  K. Polderman,et al.  Is therapeutic hypothermia immunosuppressive? , 2012, Critical Care.

[13]  K. Weant,et al.  Pharmacologic Options for Reducing the Shivering Response to Therapeutic Hypothermia , 2010, Pharmacotherapy.

[14]  A. Yli-Hankala,et al.  Prehospital induction of therapeutic hypothermia during CPR: a pilot study. , 2008, Resuscitation.

[15]  T. Heier,et al.  Impact of Hypothermia on the Response to Neuromuscular Blocking Drugs , 2006, Anesthesiology.

[16]  M. McManus.  Neuromuscular blockers in surgery and intensive care, Part 1. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[17]  D. Sigg,et al.  Facial warming increases the threshold for shivering. , 1999, Journal of neurosurgical anesthesiology.

[18]  T. Mort,et al.  The effects of forced-air warming on postbypass central and skin temperatures and shivering activity. , 1996, Journal of clinical anesthesia.

[19]  Y. Ohta,et al.  Effect of hypothermia on the in vitro potencies of neuromuscular blocking agents and on their antagonism by neostigmine. , 1994, British journal of anaesthesia.

[20]  B. Bigland,et al.  The effect of lowered muscle temperature on the action of neuromuscular blocking drugs , 1958, The Journal of physiology.